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Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System
Organ Classes Using VAERS Data
Abstract
We studied serious reports following influnza vaccine from VAERS database in year 2011. Our statistical
analyses revealed differences of reactions among different age groups and between genders. The results
may lead to additional studies to uncover factors contributing to the individual differences in
susceptibility to influenza infection.
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Abstract
We studied serious reports following influnza vaccine from
VAERS database in year 2011. Our statistical analyses
revealed differences of reactions among different age groups
and between genders. The results may lead to additional
studies to uncover factors contributing to the individual
differences in susceptibility to influenza infection.
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Introduction
Seasonal influenza is a common vaccine-preventable disease
with substantial morbidity. The social burden of seasonal flu
can be substantial [1]. Annual vaccination is the most
effective strategy to prevent influenza [2]. While their benefits
far overweigh their risks and costs, influenza vaccines are
accompanied with specific adverse events. Post-approval
surveillance of vaccine adverse events is critically needed to
assess the vaccine safety throughout its life on the market. The
Vaccine Adverse Event Reporting System (VAERS) is a
passive surveillance system to monitor vaccine safety after the
administration of vaccines licensed in the United States [3].
In this study, we explored statistical analysis on annotated
symptoms in the VAERS reports for patients with different
genders and ages.

Materials and Methods
We searched the VAERS for US reports after Trivalent
Influenza Vaccine (FLU3) in year 2011 and extracted serious
reports (i.e., death, life-threatening illness, hospitalization,
prolonged hospitalization, or permanent disability). For each
report, the VAERS provides annotations for post-vaccination
symptoms in Medical Dictionary for Regulatory Activities
(MedDRA) terms [4]. To faciliate further statistical analysis,
we further grouped these symptoms based on the MedDRA
System Organ Class (SOC) using the NCBO Web Services
[5].
To model the total number of serious symptoms per subject,
we fit a zero-truncated Poisson regression on age groups and
gender because a subject has to have at least one symptom to
be included in the VAERS database. To study the risks of
having serious symptom for each SOC type, we use logistic
regression on age groups and gender.

Results
During the study period, VAERS received 7986 FLU3
reports, 638 were serious. Out of the 638 reports, 324 were
for female patients, 295 were for male patients, and 134 ,
156, 110, 185 were for patients in age groups 0.5-17, 17-49,
49-64, and >64 repectively. 5407 symptoms were grouped
into 26 SOCs. The most frequent SOCs in the 638 reports are
nervous system disorders, general disorders, and
administration site condition and investigations.
Analysis using zero-truncated Poisson model indicated that
the avarage number of symptoms per subjects in the study
cohort is 8.74 (95% CI 6.76, 10.73). There are statistically
significant differences in number of symptoms among four
age groups and between different genders. The youngest age
group (0.5 - 17 years) has the smallest number of symptoms
per year, followed by age group 2 (17-49), age group 4 (>64),
and finally age group 3 (49 – 64). The average number of
symptoms for subjects of 17-49 years old is 13% higher than
the average number of symptoms for subjects of 0.5-17 years
old with the same gender (p=0.003).

Conclusion
This poster reports our preliminary analyses on influenza
vaccine adverse events using VAERS data and MedDRA
SOCs, which revealed differences of reactions among
different age groups and between genders. The results may
lead to additional studies to uncover factors contributing to
the individual differences in susceptibility to influenza
infection.
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